311 related articles for article (PubMed ID: 37518272)
1. A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma.
Ueda Y; Tanaka T; Asakura S; Yano T
J Clin Exp Hematop; 2023 Sep; 63(3):177-180. PubMed ID: 37518272
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD).
Sekiguchi Y; Iizuka H; Takizawa H; Sugimoto K; Sakajiri S; Inano T; Fukuda Y; Shirane S; Hamano Y; Tomita S; Izumi H; Okubo M; Nakamura N; Sawada T; Sekiguchi N; Noguchi M
Intern Med; 2020 Sep; 59(17):2165-2171. PubMed ID: 32461524
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders.
Gion Y; Doi M; Nishimura Y; Ikeda T; Filiz Nishimura M; Sakamoto M; Egusa Y; Nishikori A; Fujita A; Iwaki N; Nakamura N; Yoshino T; Sato Y
Cancer Med; 2022 Jan; 11(2):417-432. PubMed ID: 34842351
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type.
Kohno K; Suzuki Y; Elsayed AA; Sakakibara A; Takahara T; Satou A; Kato S; Nakamura S; Asano N
Am J Clin Pathol; 2020 Apr; 153(5):571-582. PubMed ID: 31977037
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series.
Ichikawa S; Fukuhara N; Saito K; Onodera K; Shirai T; Onishi Y; Yokoyama H; Fujii H; Ichinohasama R; Harigae H
Int J Hematol; 2020 May; 111(5):667-672. PubMed ID: 31955346
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.
Gion Y; Iwaki N; Takata K; Takeuchi M; Nishida K; Orita Y; Tachibana T; Yoshino T; Sato Y
Cancer Sci; 2017 Jun; 108(6):1271-1280. PubMed ID: 28380678
[TBL] [Abstract][Full Text] [Related]
7. Small intestinal follicular lymphoma induced by methotrexate: a case report.
Osaki Y; Kawaratani H; Kachi H; Matsuura K; Tsuji Y; Ozutsumi T; Takagi H; Furukawa M; Sawada Y; Mitoro A; Yamao J; Yoshiji H
BMC Gastroenterol; 2021 Jul; 21(1):280. PubMed ID: 34238226
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Harada T; Iwasaki H; Muta T; Urata S; Sakamoto A; Kohno K; Takase K; Miyamura T; Sawabe T; Asaoku H; Oryoji K; Fujisaki T; Mori Y; Yoshimoto G; Ayano M; Mitoma H; Miyamoto T; Niiro H; Yamamoto H; Oshiro Y; Miyoshi H; Ohshima K; Takeshita M; Akashi K; Kato K
Br J Haematol; 2021 Jul; 194(1):101-110. PubMed ID: 33822354
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
Hirata C; Kenzaka T; Akita H
J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases.
Yoshifuji K; Umezawa Y; Ichikawa A; Watanabe K; Miura O; Yamamoto M
In Vivo; 2019; 33(5):1599-1604. PubMed ID: 31471410
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Toyonaga H; Fukushima M; Shimeno N; Inokuma T
BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
13. [Classic Hodgkin lymphoma developing early after treatment of follicular lymphoma].
Ueda N; Hashimoto K; Yamazoe Y; Adachi Y; Kihara R; Kuwabara K; Fujino M; Watamoto K
Rinsho Ketsueki; 2020; 61(1):39-43. PubMed ID: 32023601
[TBL] [Abstract][Full Text] [Related]
14. [Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma].
Burg MR; Schneider SW
Hautarzt; 2022 Jan; 73(1):71-74. PubMed ID: 33796880
[TBL] [Abstract][Full Text] [Related]
15. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
[TBL] [Abstract][Full Text] [Related]
16. Brentuximab vedotin plus AVD followed by involved-node radiotherapy in a patient with classic Hodgkin lymphoma following gray zone lymphoma after autologous stem-cell transplantation failure.
Ueda N; Kato H; Kato S; Saito T; Tachibana H; Yanada M; Taji H; Kodaira T; Hosoda W; Yamamoto K
Hematology; 2023 Dec; 28(1):2207946. PubMed ID: 37183912
[TBL] [Abstract][Full Text] [Related]
17. [Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
Kato T; Imaizumi Y; Itonaga H; Sato S; Ando K; Sawayama Y; Ichinose K; Miyoshi H; Ohshima K; Miyazaki Y
Rinsho Ketsueki; 2023; 64(2):97-101. PubMed ID: 36990739
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic Hodgkin lymphoma without lymphadenopathy following reversible methotrexate-associated lymphoproliferative disorder.
Tsukazaki Y; Shinohara T; Tanaka K; Naruse K; Iwahara Y; Inoue S
Mod Rheumatol; 2017 Mar; 27(2):372-375. PubMed ID: 25401225
[TBL] [Abstract][Full Text] [Related]
19. Angioimmunoblastic T-cell Lymphoma Presenting as a Methotrexate-associated Lymphoproliferative Disorder with Extreme Peripheral Blood Plasmacytosis.
Murakami H; Makita M; Ishikawa T; Yoshioka T; Nagakita K; Shinno Y; Yoshino T; Maeda Y; Sunami K
Intern Med; 2022 Sep; 61(17):2655-2660. PubMed ID: 35135913
[TBL] [Abstract][Full Text] [Related]
20. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.
Shiraiwa S; Kikuti YY; Carreras J; Kondo Y; Ohmachi K; Ogawa Y; Kawada H; Sato S; Gion Y; Sato Y; Nakamura N; Ando K
Am J Surg Pathol; 2022 Aug; 46(8):1017-1024. PubMed ID: 35848760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
